Search

for
Search:

Did you mean Cardiovascular Risk Marker?

Glossary Cardiovascular Risk Marker

measurable biological characteristic indicating likelihood of cardiovascular diseases

A Cardiovascular Risk Marker, also known as a Cardiovascular Risk Factor, is a measurable biological characteristic that indicates an individual's likelihood of developing cardiovascular diseases, such as heart attacks or strokes. Common examples include high blood pressure, high cholesterol levels, and elevated blood sugar. These markers help healthcare professionals assess and manage a patient's risk for heart-related conditions.

Related Terms

Research

5 / 1000+ results

research Androgenetic alopecia - just a cosmetic defect or a biomarker and risk factor for systemic diseases? - literature review

July 2025 in “Journal of Education Health and Sport”

This review found that androgenetic alopecia may be associated with increased risks of cardiovascular disease, metabolic disorders, and mental health impacts, suggesting its potential as a biomarker for systemic conditions.

research Association Between Fish Consumption and Risk of Cardiovascular Disease Mortality in Korean Men and Women: A Prospective Cohort Study

June 2024 in “Current Developments in Nutrition”

This study indicates that DH-AVAs, when used alongside AVAs, may serve as effective biomarkers for assessing whole grain oat intake due to their longer absorption and presence in plasma.

research Love is in the hair: arginine methylation of human hair proteins as novel cardiovascular biomarkers

7 citations , June 2021 in “Amino acids”

This study found that protein arginine methylation levels in human hair may correlate with a cardiovascular biomarker in blood, suggesting hair sampling as a potential non-invasive method for cardiovascular risk assessment.

research THE IMPACT OF HOMOCYSTEINE IN LUPUS ERYTHEMATOSUS: A LINK OF INFLAMMATION, SKIN AND CARDIOVASCULAR RISK

June 2025 in “Academic Medical Journal”

This study suggests elevated homocysteine levels may serve as a biomarker for disease severity and vascular risk in cutaneous lupus erythematosus, indicating potential therapeutic benefits from B-vitamin supplementation and lifestyle changes.

research Hormonal contraceptives: pharmacology tailored to women's health

88 citations , June 2016 in “Human Reproduction Update”

This review discusses developments in oral contraceptives, highlighting improved individualization, reduced side effects, and enhanced suitability for various women's health needs, but it reports no new clinical results.

View more "cardiovascular risk biomarkers" in research →

Community Join

5 / 1000+ results

community Pattern hair loss before the age of 35 is associated with higher chances of prostate cancer, cardiovascular diseases, and metabolic syndrome later in life

1075 upvotes 3 months ago

Pattern hair loss before age 35 may be linked to higher risks of prostate cancer, cardiovascular diseases, and metabolic syndrome later in life. Finasteride is discussed as a treatment that may lower PSA levels and potentially prevent prostate issues.

community Oral Minoxidil: Dosing, Timing, PE Risk, and Why Your Weight Matters (with actual data)

223 upvotes 4 months ago

Oral minoxidil dosing should be based on body weight to minimize side effects, with higher doses increasing risks like pericardial effusion. Combining oral minoxidil with topical treatments and finasteride can improve hair growth, but regular heart health monitoring is essential.

community 57% increased chance of pattern hair loss independently associated with the consumption of sugary beverages in men (p<0.001).

297 upvotes 2 years ago

Sugary beverages increase the risk of pattern hair loss in men by 57%, and type 2 diabetes is linked to female pattern hair loss. Reducing sugar intake and using treatments like finasteride and minoxidil may help manage hair loss.

community Being Safe on Oral Minoxidil: tl;dr on the literature.

51 upvotes 1 year ago

Oral minoxidil is effective for hair loss but can cause cardiovascular side effects, such as pericardial effusion, especially in those with genetic predispositions. Starting with low doses and monitoring cardiovascular health are advised to reduce risks.

community Has anyone find a way to stop/limit ru58841 to go systematic ?

in Finasteride/Dutasteride 4 upvotes 1 year ago

RU58841 is a strong non-steroidal antiandrogen for hair loss but may cause cardiovascular issues in some users. Alternatives like Pyrilutamide and Breezula are suggested due to better safety profiles and lower systemic risks.

View more "cardiovascular risk biomarkers" in community →

Learn

— no results

Try a deeper search in learn →

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →